PULSION Medical Systems SE Announces Group Financial Results for the Second Quarter and Six Months Ended June 30, 2013; Provides Earnings Guidance for the Year of 2013
For the six months, the company reported sales of 18.534 million against 17.269 million a year ago. Profit before interest and taxes (EBIT) was 4.807 million against 4.793 million a year ago. EBITDA was 5.722 million against 5.789 million a year ago. Group net profit was 4.164 million or 0.51 per diluted share against 3.617 million or 0.24 per diluted share a year ago. Cash flow from operating activities before changes in net working capital was 1.332 million against 3.376 million a year ago. Cash flow from operating activities after changes in net working capital was 2.368 million against 5.713 million a year ago. Operating profit was 4.977 million against 4.752 million a year ago. Purchase of intangible assets was 0.522 million against 0.013 million a year ago. Purchase of property, plant and equipment (incl. monitors) was 0.512 million against 0.716 million a year ago.
For the full financial year 2013 the company is targeting sales growth of at least 6 %, which would entail a slight acceleration in the growth rate compared to the previous year. After the actual results for the first quarter 2013 became known, a target-EBIT corridor of 24 % to 28 % was announced as guidance for the full year 2013; it considers that this guidance remains realistic. Earnings per share are expected to be within a range of 0.95 to 1.05, approximately 20 % higher than the previous year's figure of 0.82.